Actively Recruiting
The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
Led by Indiana University · Updated on 2025-04-11
850
Participants Needed
1
Research Sites
211 weeks
Total Duration
On this page
Sponsors
I
Indiana University
Lead Sponsor
E
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
CONDITIONS
Official Title
The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children enrolled in the Tabiri study (R01HD104552)
- Children exposed to HIV but uninfected (CHEU) or children not exposed to HIV and uninfected (CHUU)
- Children aged 24 to 72 months
- Caregivers of children must speak Kiswahili or English
You will not qualify if you...
- No specific exclusion criteria; children who develop HIV prior to enrollment will be included and follow all study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Moi Teaching and Referral Hospital
Eldoret, Kenya, Kenya
Actively Recruiting
Research Team
R
Rebecca McNally Keehn, PhD, HSPP
CONTACT
B
Brandon Keehn, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here